Cancer Patients in U.S. Live Longer, Study Says
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
Cancer patients in America, Japan, and France live longer than those elsewhere because of early diagnosis and treatment, according to the first worldwide study of survival rates of the disease.
The research, published today in the Lancet Oncology, looked at 2 million patients with the most-common forms of the disease and found the highest survival rates among breast and prostate cancer patients in America, colon and rectal cancers in men in Japan, and the same cancers among women in France.
